ICU Medical, Inc. (ICUI)

ICU Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ICU Medical stock have an average target of 177.25, with a low estimate of 110 and a high estimate of 209. The average target predicts an increase of 13.03% from the current stock price of 156.82.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$110	$177.25	$200	$209
Change	-29.86%	+13.03%	+27.53%	+33.27%

Analyst Ratings

The average analyst rating for ICU Medical stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	1	1	2
Buy	2	2	2	2	2	2
Hold	1	1	1	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Toomey Jefferies	Jefferies	Hold → Strong Buy Upgrades $200	Hold → Strong Buy	Upgrades	$200	+27.53%	Dec 11, 2024
Brett Fishbin Keybanc	Keybanc	Buy Maintains $198 → $209	Buy	Maintains	$198 → $209	+33.27%	Nov 13, 2024
Mike Matson Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 13, 2024
Brett Fishbin Keybanc	Keybanc	Buy Maintains $147 → $198	Buy	Maintains	$147 → $198	+26.26%	Oct 15, 2024
Michael Toomey Jefferies	Jefferies	Hold Initiates $183	Hold	Initiates	$183	+16.69%	Oct 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.36B

Increased by 4.38%

from 2.26B

Revenue Next Year

2.37B

Increased by 0.34%

from 2.36B

EPS This Year

5.71

from -1.23

EPS Next Year

7.27

Increased by 27.28%

from 5.71

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.27B	1.27B	1.32B	2.28B	2.26B	2.36B	2.37B	2.44B
Revenue Growth	-9.56%	0.38%	3.56%	73.21%	-0.92%	4.38%	0.34%	3.00%
EPS	4.69	4.02	4.74	-3.11	-1.23	5.71	7.27	8.71
EPS Growth	252.63%	-14.29%	17.91%	-	-	-	27.28%	19.78%
Forward PE	-	-	-	-	-	27.45	21.56	18.00
No. Analysts	-	-	-	-	-	8	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	2.4B	2.5B	2.7B
Avg	2.4B	2.4B	2.4B
Low	2.2B	2.0B	2.1B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	8.3%	8.1%	12.6%
Avg	4.4%	0.3%	3.0%
Low	-0.8%	-13.9%	-10.5%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	5.95	7.83	9.38
Avg	5.71	7.27	8.71
Low	5.43	6.53	8.03

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	37.1%	28.9%
Avg	-	27.3%	19.8%
Low	-	14.2%	10.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.